Skip to content

Characteristics and the Future of the City Chilblains

Characteristics and the Future of the City Chilblains

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03101761
Enrollment
50
Registered
2017-04-05
Start date
2016-02-01
Completion date
2017-02-28
Last updated
2017-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chilblains

Brief summary

Chilblains are cutaneous lesions affecting extremities (foot and fingers) with erythemic papules, evolving by painful relapse due to cold and sudden reheating. This pathology is currently poorly understood while it's frequent. The aim of the study is to evaluate all the characteristics of this pathology by reporting clinical and biological data of patient consulting for chilblains; and the other point is to assess the evolution of these patients.

Detailed description

Investigators are going to collect data on patient medical report to fill up a case report form. And in a second time they call patient by phone to ask him/her about the evolution of their pathology.

Interventions

None listed

Sponsors

Fondation Hôpital Saint-Joseph
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* patient consulting for chilblains * diagnostic of chilblain during the consultation

Exclusion criteria

* patients consulting for other reason than chilblains * patient who can't reply by telephonic call

Design outcomes

Primary

MeasureTime frameDescription
Évaluation of chilblains' topographyDay 1This assessment consists to evaluate the chilblains topography, vasospastic profile and presence or not of another acrosyndrome

Secondary

MeasureTime frame
Questionnaire of assessment of chilblains' evolution2 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026